@jforcsjournal

Journal for Clinical Studies is a peer reviewed journal which details practical & theoretical operational procedures, challenges and regulatory guidelines.

 London, England
journalforclinicalstudies.com/
Joined April 2016
  • Tweets1.4K
  • Following30
  • Followers76
371Media
WHAT SOLUTIONS DO GOVERNMENT AND OPPOSITION PARTIES HAVE FOR LONG-TERM HEALTH FUNDING AND PLANNING? The House of Lords Committee on the Long... journalforclinicalstudies.co… journalforclinicalstudies.co…

WHAT SOLUTIONS DO GOVERNMENT AND OPPOSITION PARTIES HAVE FOR LONG-TERM HEALTH FUNDING AND PLANNING?...

The House of Lords Committee on the Long-Term Sustainability of the NHS will next week take evidence from a star line-up of witnesses including Health

journalforclinicalstudies.com
1
51
Overcoming the Challenges of Obtaining Informed Consent During the Pandemic The COVID-19 pandemic created a public h... journalforclinicalstudies.co… journalforclinicalstudies.co…
28
Artificial Intelligence in Life Sciences – How Far Can it Go? AI, or artificial intelligence, is one o... journalforclinicalstudies.co… journalforclinicalstudies.co…

Artificial Intelligence in Life Sciences – How Far Can it Go? - Journal for Clinical Studies

AI, or artificial intelligence, is one of the most hyped terms to emerge in technology over the past decade. Despite that hype, it does possess the potential

journalforclinicalstudies.com
17
FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder As the United States' opioid epidemic r... journalforclinicalstudies.co… journalforclinicalstudies.co…
34
Innoviva subsidiary Entasis scores FDA nod for bacterial pneumonia combo drug Xacduro In financial distress last May, AstraZe... journalforclinicalstudies.co… journalforclinicalstudies.co…

Innoviva subsidiary Entasis scores FDA nod for bacterial pneumonia combo drug Xacduro - Journal for...

In financial distress last May, AstraZeneca spinout Entasis Therapeutics sold out to holding company Innoviva for $113 million. A year later—to the

journalforclinicalstudies.com
38
Getting Results with eLearning Getting Results with eLearning In a phar... journalforclinicalstudies.co… journalforclinicalstudies.co…

Getting Results with eLearning - Journal for Clinical Studies

Getting Results with eLearning In a pharma clinical department or a CRO, there may well be groups of staff, perhaps in worldwide locations, who need to be

journalforclinicalstudies.com
4
Deep Brain Stimulation Could Address Suicide Risk in Individuals Resistant to Treatment Pharmaceutical and behavioural therapy t... #BEHAVIOURALTHERAPY #MAJORDEPRESSIVEDISORDER #MDD #MENTALHEALTH #PHARMACEUTICAL #POSTTRAUMATICSTRE... journalforclinicalstudies.co…

Deep Brain Stimulation Could Address Suicide Risk in Individuals Resistant to Treatment - Journal...

Analysis of deep brain stimulation that can address suicide risk in individuals resistant to treatment.

journalforclinicalstudies.com
22
Allergan's new skin-smoothing product gets FDA nod—with novel delivery mechanism AbbVie'saesthetics unit is growin... journalforclinicalstudies.co… journalforclinicalstudies.co…
7
Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine Sandoz, a Novartis division and a globa... journalforclinicalstudies.co… journalforclinicalstudies.co…

Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple...

Under the agreement, Polpharma Biologics will maintain responsibilities for development, manufacturing and supply of proposed biosimilar natalizumab. Sandoz

journalforclinicalstudies.com
29
The Four Criteria of a Perfect Eligibility Form Bryan Farrow of OpenClinica examines h... journalforclinicalstudies.co… journalforclinicalstudies.co…

The Four Criteria of a Perfect Eligibility Form - Journal for Clinical Studies

Bryan Farrow of OpenClinica examines how we should approach eligibility at the level of data management and workflow optimisation, offering some best

journalforclinicalstudies.com
11
AvKARE bottles mix Viagra generics with antidepressant, triggering recall A generic drugmaker with a Rolodex full... journalforclinicalstudies.co… journalforclinicalstudies.co…
3
Coming Soon Coming Soon journalforclinicalstudies.co… journalforclinicalstudies.co…
6
THE PHARMACEUTICAL MANUFACTURING AND PACKAGING CONGRESS (PHARMAP 2023) 12-13, June 2023 in Geneva, Switzerland... journalforclinicalstudies.co… journalforclinicalstudies.co…
22
Cardiovascular Safety Watch Column Cardiovascular Safety Watch Column This ... journalforclinicalstudies.co… journalforclinicalstudies.co…

Cardiovascular Safety Watch Column - Journal for Clinical Studies

Cardiovascular Safety Watch Column This column focuses on a recent paper from the Cardiac Safety Research Consortium (CSRC) entitled “Cardiac Imaging

journalforclinicalstudies.com
4
COVID-19 more severe in colder months, research suggests Environmental temperature and humidity ... journalforclinicalstudies.co… journalforclinicalstudies.co…

COVID-19 more severe in colder months, research suggests - Journal for Clinical Studies

Environmental temperature and humidity have an effect on the severity of COVID-19 symptoms, researchers from Europe and China have concluded.

journalforclinicalstudies.com
5
With U.S. elections nearing, European pharma giants brace for potential pricing action With U.S. presidential and congressiona... journalforclinicalstudies.co… journalforclinicalstudies.co…

With U.S. elections nearing, European pharma giants brace for potential pricing action - Journal...

With U.S. presidential and congressional campaigns in full swing, it’s not just Americans anxiously awaiting the results of the upcoming elections. The races

journalforclinicalstudies.com
5
FDA delays decision on Moderna's COVID-19 vaccine in 12-17 age group because of myocarditis concerns After reports in four Nordic countries o... #COVID19 #FDA #HEARTINFLAMMATION #KIDS12TO17 #MODERNA #MYOCARDITIS #NORDIC ... journalforclinicalstudies.co…
1
52
Beating its rivals, GSK nabs world-first approval for adult RSV vaccine Arexvy In landing an FDA approval for its high... journalforclinicalstudies.co… journalforclinicalstudies.co…

Beating its rivals, GSK nabs world-first approval for adult RSV vaccine Arexvy - Journal for...

In landing an FDA approval for its highly anticipated respiratory syncytial virus (RSV) vaccine, GSK has both beat out its market rivals and initiated its

journalforclinicalstudies.com
9
As Amgen's revenues slide, so too do sales at its big buyout target Horizon As Horizon works to close its $28 billi... journalforclinicalstudies.co… journalforclinicalstudies.co…
28
ImmunoGen touts 'home run' as ovarian cancer drug Elahere extends lives in landmark trial win ImmunoGen has shaken off a previous pha... journalforclinicalstudies.co… journalforclinicalstudies.co…

ImmunoGen touts 'home run' as ovarian cancer drug Elahere extends lives in landmark trial win -...

ImmunoGen has shaken off a previous phase 3 flop for its ovarian cancer antibody-drug conjugate Elahere with what its CEO is calling a “home run” trial

journalforclinicalstudies.com
30
Load more